Modulators of HIF1α and NFkB in Cancer Treatment: Is it a Rational Approach for Controlling Malignant Progression?
about
The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapyTumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression.Molecular mechanisms of hypoxia in cancer.In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer.Estradiol represses the G(D3) synthase gene ST8SIA1 expression in human breast cancer cells by preventing NFκB binding to ST8SIA1 promoter.Distinct phenotypes of human prostate cancer cells associate with different adaptation to hypoxia and pro-inflammatory gene expression.The oncoprotein HBXIP promotes glucose metabolism reprogramming via downregulating SCO2 and PDHA1 in breast cancer.Proinflammatory and Anti-Inflammatory Cytokines Mediated by NF-κB Factor as Prognostic Markers in Mammary Tumors.Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in Cancer.Hair curvature: a natural dialectic and review.Development and characterization of resveratrol nanoemulsions carrying dual-imaging agents.Apoptotic Effect of Sanggenol L via Caspase Activation and Inhibition of NF-κB Signaling in Ovarian Cancer Cells.Capsaicin: a novel radio-sensitizing agent for prostate cancer.Acetylshikonin Inhibits Human Pancreatic PANC-1 Cancer Cell Proliferation by Suppressing the NF-κB Activity.Anti-Metastatic Effect of Semi-Purified Nuphar Lutea Leaf ExtractsTumor angiogenesis revisited: Regulators and clinical implications.Molecular Pathways: The Balance between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor-κB Signaling for Cancer TreatmentAssessment of Hepatocellular Carcinoma Metastasis Glycobiomarkers Using Advanced Quantitative N-glycoproteome Analysis.Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer.NF-kappaB: Two Sides of the Same Coin.Human placenta mesenchymal stem cells promote axon survival following optic nerve compression through activation of NF-κB pathway.The role of NFκB in spheroid formation of human breast cancer cells cultured on the Random Positioning Machine.PD-L1, inflammation, non-coding RNAs, and neuroblastoma: Immuno-oncology perspective.Hypoxia and Inflammation in Cancer, Focus on HIF and NF-κB.COPD-Type lung inflammation promotes K-ras mutant lung cancer through epithelial HIF-1α mediated tumor angiogenesis and proliferation
P2860
Q28067724-009C1C7E-8E8F-48C4-AF30-05E23EC3AC2FQ33674627-45054383-9506-4AD9-99A8-432CCBB29AA4Q33705108-EBDE6E85-E23F-4840-9DB1-A1446B6849FCQ33805335-DE6F50D6-A6BF-48F2-9358-84DFFD511B4FQ34693290-F72BB331-8625-42DA-AB0E-57199010009CQ35163931-685AE88C-5D4D-4A89-B036-59AD903E7741Q36413734-55439122-CA0E-4E48-90DA-795657D55B7FQ36632887-AEFAF97D-81A8-4AE4-88C6-EE99EEA7A724Q38166232-790E32EB-BAAE-4195-876B-D2379A8AEA7BQ38195115-52702A9C-BCE9-42AF-AC3E-660018C4AFE7Q38796488-2682BC94-90F5-4D2D-9D75-917E61DFA202Q38820413-F36BC35F-3611-449D-9145-19CE919C1334Q38948728-4EA4D564-EE59-4697-A38B-CDC37BE3FE92Q38967720-256C1813-C010-4C48-8074-DA92F4E306EBQ39332430-CD39C744-A1DC-40FC-9253-5361C5A9B2FEQ39393740-F1CFA015-E56C-4291-AB57-A8C100102323Q40648639-D470324B-7BD0-4C4B-AB72-F7DBC1CD9A0FQ40955052-B0D28E17-066E-4427-B610-D4720C8BD7CFQ42375241-7583DCE9-46CC-4FF6-AD1C-79D7788A26B0Q47556651-6596D706-5278-47D5-8762-BDB38E945AE5Q47878236-A5307671-14A7-4869-9C07-4BE032F0E206Q48223429-D1E972C5-B7A3-4A6C-B9D4-7BE7A7D8676BQ49357462-41E9F0D2-330E-48AC-B256-D25C94F19C2FQ54858561-8788FD32-1686-40FE-9915-8CED8C176D45Q58779415-CF39972E-FE53-4141-AABA-2D29B5DB38EE
P2860
Modulators of HIF1α and NFkB in Cancer Treatment: Is it a Rational Approach for Controlling Malignant Progression?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Modulators of HIF1α and NFkB i ...... rolling Malignant Progression?
@en
type
label
Modulators of HIF1α and NFkB i ...... rolling Malignant Progression?
@en
prefLabel
Modulators of HIF1α and NFkB i ...... rolling Malignant Progression?
@en
P2093
P2860
P356
P1476
Modulators of HIF1α and NFkB i ...... rolling Malignant Progression?
@en
P2093
Andrea Russo
Bruna Pucci
Elisa Petrangeli
Giulietta A Perrone
Laura Pellegrini
Linda Ravenna
Luana Schito
Luisa Salvatori
Marco Tafani
Matteo A Russo
P2860
P356
10.3389/FPHAR.2013.00013
P577
2013-02-12T00:00:00Z